MONDAY, OCTOBER 23, 2017

Experimental Ebola drug ZMapp requires further research

ZMapp, an experimental treatment for the Ebola virus, may be beneficial to Ebola patients but there is still a lack of data from its developer, Mapp Biopharmaceutical Inc., to determine whether it can be used to treat humans. Read More »

Liberian study shows experimental Ebola vaccines are immunogenic and well-tolerated

Two investigational Ebola vaccines have been tested and proved to be immunogenic and well-tolerated among 1,500 participants in a randomized, placebo-controlled clinical trial. Read More »

Vaginal ring with antiretroviral drug offers partial HIV protection

The National Institutes of Health recently conducted studies that show an antiretroviral drug within a vaginal ring may be the strongest protector for women against HIV infections. Read More »

Maryland researchers discover potential MERS treatment

Scientists at the University of Maryland School of Medicine recently found a potential new treatment for Middle East Respiratory Syndrome (MERS) that uses genetically modified cows to produce antibodies to fight the infection. Read More »

Study shows CMV vaccine is effective against Ebola

A recent study shows the cytomegalovirus (CMV) vaccine may be effective in protecting people from contracting the Ebola virus, which caused a recent outbreak in West Africa. Read More »

Research shows HIV reservoirs refill through replication during treatments

Scientists from the National Institutes of Allergy and Infectious Diseases recently conducted a study demonstrating that ongoing HIV replication continues even during antiretroviral therapy (ART) treatments. Read More »

Profectus BioSciences launches phase 1 clinical trial for Ebola vaccine

Profectus BioSciences Inc., a clinical-stage vaccine company that creates vaccines to prevent and treat infectious diseases and cancers, recently began its Phase 1 clinical trial to evaluate the immunogenicity and safety of the company’s Ebola virus. Read More »

Global coordinator pushes for stronger, more focused anti-HIV efforts

Dr. Deborah Birx, the U.S. Global AIDS Coordinator who monitors the President’s Emergency Plan for AIDS Relief (PEPFAR), recently called for stronger efforts against HIV infections around the world as she presented at the National Institutes of Health (NIH). Read More »

Brazil launches Phase 3 trial for dengue vaccine

Researchers from the Butantan Institute, a nonprofit manufacturer of immunobiologic solutions for Brazil, recently launched a multi-center, controlled Phase 3 trial that will examine an investigational dengue fever vaccine. Read More »

NIAID highlights accomplishments from 2015

The National Institute of Allergy and Infectious Diseases (NIAID), a branch of the National Institutes of Health, recently released a slideshow that emphasizes the notable scientific progress that NIAID researchers have accomplished for 2015. Read More »

Immune responses may inhibit antibody-based treatments for HIV

Researchers from the Medical University of South Carolina recently conducted studies to determine whether immune responses inhibit the results of broadly neutralizing antibody treatments that may help people with HIV infections. Read More »

NIH outlines strategic plan, initiatives for 2016

NIH has published its strategic plan and initiatives for 2016 as a result of the solicitation of NIH advisory councils. Read More »

Two new studies explore containment options for camel-transmitted MERS

While camels are useful and beloved creatures, they also harbor the ability to transmit to humans communicable forms of MERS coronavirus. Read More »

Illinois study shows emerging, bacteria-targeting uses from medications

A new study led by Illinois chemistry professor Eric Oldfield has found new uses for medications brought to market to treat cancer, fertility issues and particular types of infections.  Read More »

Scientists map the spread of Ebola in West Africa

Scientists recently developed a map that outlines the spread of Ebola in Western Africa, which will help them to better understand how the virus is transmitted. Read More »

Liberian officials provide latest update on Ebola outbreak

Liberian health officials have released the latest Ebola numbers in a report confirming that all individuals who had contact with the last three confirmed human cases have finished their 21-day quarantines and follow-up appointments. Read More »

FDA gives priority status to PaxVax's cholera vaccine

The U.S. Food and Drug Administration (FDA) recently gave a priority review status to a Biologics License Application for filing and reviewing a single-dose oral cholera vaccine known as Vaxchora. Read More »

Trial of H7N9 influenza vaccine boost shows positive results

Researchers from the National Institute of Allergy and Infectious Diseases (NIAID) have conducted a small clinical trial of a prime-boost for H7N9 influenza vaccines to provoke a better, stronger immune response against the virus. Read More »

NIH researchers create HIV prevention and treatment guidelines

National Institutes of Health (NIH) researchers at the National Institute of Allergy and Infectious Diseases (NIAID) recently used three clinical studies to create guidelines for preventing and treating HIV infections. Read More »

Texas Biomed gains grant to develop cure for HIV-born babies

The Texas Biomedical Research Institute (TBRI) recently gained a $5 million National Institutes of Health grant to fund the organization’s research for potential functional cures for babies who are born with human immunodeficiency virus (HIV) infections. Read More »